MedTrace Logo

A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health

NCT06911073 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-09-09

No results posted yet for this study

Summary

This study aims to evaluate the impact of a specific oral postbiotic supplement on metabolic health in overweight adults.

Conditions

  • Obesity and Overweight

Interventions

DIETARY_SUPPLEMENT

Postbiotic

Active ingredients: Vitamin D (as cholecalciferol) - 10 mcg Vitamin B12 (as methylcobalamin) - 200 mcg Chromium (as chromium picolinate) - 600 mcg resM™ Postbiotic (L. plantarum RSB11® HI - 16B cells) - 40 mg White mulberry (Morus alba) leaf extract - 250 mg Fenugreek (Trigonella foenum-graecum) seed extract - 200 mg Inactive ingredients: Microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate, silica, water, carrageenan, potassium acetate

DIETARY_SUPPLEMENT

Placebo

Active ingredients: N/A Inactive ingredients: Microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate, silica, water, carrageenan, potassium acetate

Sponsors & Collaborators

  • Able Biolabs, LLC

    collaborator OTHER

  • ResBiotic Nutrition, Inc.

    lead INDUSTRY

Principal Investigators

  • Ahmed Abdelgawad, MD · Able Biolabs, LLC

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-02
Primary Completion
2025-11-30
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06911073 on ClinicalTrials.gov